Αρχική
Τύποι καρκίνου
Θεραπείες
Υποστήριξη
Νέα
Κέντρα και ογκολόγοι
Αναζήτηση
Δευτέρα, Νοέμβριος 16, 2026
Ogkologos.com
Αρχική
Τύποι καρκίνου
Θεραπείες
Υποστήριξη
Νέα
Κέντρα και ογκολόγοι
Αρχική
Δημιουργοί
Δημοσιεύσεις από Ogkologos
Ogkologos
4399 ΔΗΜΟΣΙΕΥΣΕΙΣ
0 ΣΧΟΛΙΑ
Cancer vaccines and the next frontier in melanoma: From headlines to...
Ogkologos
-
14 Οκτωβρίου, 2026
0
Five-Year Survival Outcomes with Neoadjuvant Therapy in Melanoma Demonstrate that Neoadjuvant...
Ogkologos
-
13 Οκτωβρίου, 2026
0
Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated...
Ogkologos
-
12 Οκτωβρίου, 2026
0
EMA Recommends Granting a Marketing Authorisation for Ensartinib
Ogkologos
-
9 Οκτωβρίου, 2026
0
Taking on the RAS Challenge
Ogkologos
-
8 Οκτωβρίου, 2026
0
Adjuvant fractionated radiotherapy significantly improves DFS in patients with atypical meningioma...
Ogkologos
-
8 Οκτωβρίου, 2026
0
ESMO Calls for the European Commission to Propose an EU Directive...
Ogkologos
-
7 Οκτωβρίου, 2026
0
ESMO contributes to discussions on the future of cancer care at...
Ogkologos
-
7 Οκτωβρίου, 2026
0
FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and...
Ogkologos
-
7 Οκτωβρίου, 2026
0
Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance...
Ogkologos
-
6 Οκτωβρίου, 2026
0
1
...
3
4
5
...
440
Σελίδα 4 από 440
MOST POPULAR
The RAD51-IF Test Is Feasible for Assessment of the Functional Status...
7 Μαΐου, 2021
Our 10 top tips to help you talk about cancer
24 Απριλίου, 2023
Study Offers Insights on Health Problems among AYA Cancer Survivors
7 Αυγούστου, 2020
Savolitinib Shows Promise in Pulmonary Sarcomatoid Carcinoma and Other METex14-positive NSCLC...
23 Ιουνίου, 2021
Φόρτωση περισσοτέρων
HOT NEWS
Five Fraction SBRT Noninferior to Moderately Fractionated Image-Guided Radiotherapy for Patients...
Pembrolizumab Does Not Prolong Overall Survival Compared to Chemotherapy in Platinum-Pretreated...
Lung Cancer Trial of Osimertinib Draws Praise—and Some Criticism
ESMO Welcomes European Parliament Resolution Marking World Cancer Day
Ελληνικά
English (UK)